Literature DB >> 4188623

Metabolic and clinical effects of glibenclamide.

M Davidson, A A Lewis, R R De Mowbray, B J Boucher, N W Oakley, J D Nabarro, J Ginsburg, P Beaconsfield.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 4188623     DOI： 10.1016/s0140-6736(70)91844-1

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

1.  Glucose tolerance, plasma insulin and lipids in diabetic subjects before and after treatment with a new sulfonylurea compounds, Ro 6-4563.

Authors:  P Berchtold; P Björntorp; A Gustafson; A Jonsson; S E Fagerberg
Journal:  Eur J Clin Pharmacol       Date:  1971-12       Impact factor: 2.953

Review 2.  The relationship between the pharmacokinetics and pharmacodynamic effects of oral hypoglycaemic drugs.

Authors:  R E Ferner; S Chaplin
Journal:  Clin Pharmacokinet       Date:  1987-06       Impact factor: 6.447

3.  Letter: Glibenclamide-induced hypoglycaemia.

Authors:  D O Sillence; J M Court
Journal:  Br Med J       Date:  1975-08-23

4.  Hormonal and metabolic effects of chlorpropamide, glibenclamide and placebo in a cross-over study in diabetics not controlled by diet alone.

Authors:  P H Sönksen; C Lowy; J R Perkins; T E West
Journal:  Diabetologia       Date:  1981       Impact factor: 10.122

Review 5.  Glibenclamide: a review.

Authors: 
Journal:  Drugs       Date:  1971       Impact factor: 9.546

Review 6.  Problems and pitfalls of sulphonylurea therapy in older patients.

Authors:  D A Robertson; P D Home
Journal:  Drugs Aging       Date:  1993 Nov-Dec       Impact factor: 3.923

7.  The effect of acebutolol and propranolol on the hypoglycaemic action of glibenclamide.

Authors:  R Zaman; M J Kendall; P I Biggs
Journal:  Br J Clin Pharmacol       Date:  1982-04       Impact factor: 4.335
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.